Corrigendum to "New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies" [Biomed. Pharmacother. 161 (2023) 114491]
1 Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, UP, India.
2 Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, UP, India. Electronic address: fahadintegralian@gmail.com.
3 Department of Biotechnology, Parul Institute of Applied Sciences and Centre of Research for Development, Parul University, Vadodara 391760, India.
4 Chansol Hospital of Korean Medicine, 290, Buheung-ro, Bupyeong-gu, Incheon 21390, the Republic of Korea; Department of Pathology, College of Korean Medicine, Kyung Hee University, Hoegidong Dongdaemun-gu, Seoul 02447, the Republic of Korea.
5 Department of Pathology, College of Korean Medicine, Kyung Hee University, Hoegidong Dongdaemun-gu, Seoul 02447, the Republic of Korea; Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, the Republic of Korea.
6 Department of Pathology, College of Korean Medicine, Kyung Hee University, Hoegidong Dongdaemun-gu, Seoul 02447, the Republic of Korea; Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, the Republic of Korea. Electronic address: bongleekim@khu.ac.kr.